Formation Bio’s Post

Formation Bio's Melanie Hullings and Laura Fazio, MS will be presenting at PHUSE on July 25th in Pennsylvania. We hope to see you there! -- In the era of AI and advanced analytics propelling data management forward at an exponential rate, partnership between Clinical Data Managers and Clinical Data Scientists is critical. Laura and Mel will discuss how these teams at Formation Bio work together to create fit-for-purpose tools to automate data cleaning, reporting and analytics. They will also share perspectives on where AI-driven solutions will fit into the clinical data ecosystem and solicit feedback on the gaps that still need filling to support real-time data-driven decisions. More confernece details here: https://rb.gy/r2yctv #datascience #biotech #pharma #drugdevelopment #clinicaltrials #clinicaldatamanagement

Today we announced our $372MM Series D financing, led by Andreessen Horowitz with major participation from Sanofi. Existing investors also joined this round, including Sequoia Capital, Thrive Capital, Lachy Groom, and Emerson Collective, along with new investors SV Angel Growth and FPV Ventures and others. At Formation Bio, we are building the pharma company of the future, where human expertise and AI collaborate seamlessly to make drug development and clinical trials dramatically more efficient. As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently. We are proud to partner with best-in-class investors and advisors from both pharma and tech backgrounds along the way. Read more here: https://lnkd.in/et6uKzGV #pharma #biotech #funding #fundraise #tech #ai #drugdevelopment

We are excited to announce our collaboration with OpenAI and Sanofi to build fine-tuned and custom AI solutions to transform drug development. Since our inception, we have focused on building a pharma company differentiated by radical efficiency throughout drug development and clinical trials - and this collaboration helps us advance that vision.    As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently. You can read more about the collaboration here: https://lnkd.in/eYx9_QYg #ai #drugdevelopment #clinicaltrials #pharma #biotech

Formation Bio will be attending PharmaSUG 2024! Our team members Helena Belloff Melanie Hullings Andrew Burd Emily Murphy Laura Fazio, MS will be presenting on May 20th and 21st - we hope to see you there! Details below. #software #datascience #pharma #biotech #conference #baltimore #statisticalprogramming #research #clinicaldevelopment #PharmaSUG2024

We have had an exciting Q1 at Formation Bio! We are thrilled to introduce our newest team members Amanda Hyler, Jamie C., Marianne Hawes, Joseph St.Amand, Gina DiGello, Benjamin Miles, Debra Wallace, and Jennifer Kang.